| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/28/2008 | EP1924594A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 05/28/2008 | EP1924593A1 Hcv ns3 protease inhibitors |
| 05/28/2008 | EP1924278A2 A kit of lyophilized thrombin and lyophilized fibrinogen used to compound fibrin membrane, and its application |
| 05/28/2008 | EP1301604B1 Substrates and assays for beta-secretase activity |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | CA2569204A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378397 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/22/2008 | WO2008060552A2 Synthetic peptide amides and dimers thereof |
| 05/22/2008 | WO2008058679A2 Novel amides acting on the adenosine receptors |
| 05/22/2008 | WO2007097903A3 Hiv fusion inhibitor peptides with improved biological properties |
| 05/22/2008 | CA2669310A1 Hepatitis c virus inhibitors |
| 05/22/2008 | CA2669162A1 Novel amides acting on the adenosine receptors |
| 05/22/2008 | CA2667460A1 Synthetic peptide amides and dimers thereof |
| 05/21/2008 | EP1922327A2 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 05/21/2008 | EP1495318A4 Method for detecting ligands and targets in a mixture |
| 05/21/2008 | CN101184769A Diagnostic and therapeutic agents |
| 05/21/2008 | CN101184755A Peptidomimetic compounds and preparation of biologically active derivatives |
| 05/20/2008 | US7375218 highly convergent and this convergency manifests itself in a much shorter synthetic sequence |
| 05/20/2008 | US7375086 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases; Nucleotide sequences coding protein for use in the treatment of crohn's disease |
| 05/20/2008 | US7375085 Melanocyte-stimulating hormone inhibitors |
| 05/20/2008 | CA2219819C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2219818C Novel compounds, the preparation and use thereof |
| 05/15/2008 | WO2008057873A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057608A2 Synthetic peptide amides |
| 05/15/2008 | WO2008057209A1 Hcv ns3 protease inhibitors |
| 05/15/2008 | WO2008055488A1 Michael systems as transglutaminase inhibitors |
| 05/15/2008 | WO2008036258A3 Collyrium for dry eye |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | US20080113909 Compositions and Methods for Treating Stat-6 Associated Diseases or Conditions |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | DE102006052755A1 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| 05/15/2008 | CA2667155A1 Synthetic peptide amides |
| 05/15/2008 | CA2667032A1 Hcv ns3 protease inhibitors |
| 05/15/2008 | CA2667031A1 Hcv ns3 protease inhibitors |
| 05/15/2008 | CA2662876A1 Michael systems as transglutaminase inhibitors |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1919904A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/14/2008 | EP1919492A2 Growth hormone secretagogues |
| 05/14/2008 | EP1919491A2 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/14/2008 | EP1529057B1 Biphalin derivatives and their analgesic applications |
| 05/14/2008 | CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 05/14/2008 | CN100387615C Preparation method of N-carboxyalkyl dipeptide type angiotensin converting enzyme inhibitor |
| 05/14/2008 | CN100387296C New dialysis method |
| 05/13/2008 | US7371872 (1R,4S,5S,6S)-4-(2'S-4'-methylthio-2'-aminobutanonyl)amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid; nervous system, psychological, and psychiatric disorders |
| 05/13/2008 | US7371867 Non-racemic trifluoroleucine, and methods of making and using |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders |
| 05/13/2008 | US7371411 oxidized glutathione-based compound having a stabilized disulfide bond |
| 05/13/2008 | US7371364 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/08/2008 | WO2008054250A1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 05/08/2008 | WO2008052428A1 Preparation method and conjugate with drug molecule thereof |
| 05/08/2008 | WO2008014229A3 Dimeric iap inhibitors |
| 05/08/2008 | WO2007124284B1 Bombesin receptor anatogonists with anti-cancer activity |
| 05/08/2008 | WO2006056487A3 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108692 Alkylene selenocyanate or an alkylene isoselenocyanate moiety; anticancer agents; food supplements; 1,4-phenylenebis(alkylene)selenocyanate |
| 05/08/2008 | US20080108576 Novel cytostatic conjugates with integrin ligands |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917269A2 Inhibitors of serine proteases |
| 05/07/2008 | EP1758923B8 Peptide substance restoring myocardium function |
| 05/07/2008 | EP1758922B8 Peptide substance restoring function of respiratory organs |
| 05/07/2008 | EP1649036B1 Method for producing cyclic molecules |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1356036B1 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/07/2008 | CN101172997A Oligopeptide or its modified compound/derivant and application thereof |
| 05/06/2008 | US7368628 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 05/06/2008 | US7368580 Method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 05/06/2008 | US7368529 Protein isolated from plants (Moringa) or recombinant DNA; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 05/06/2008 | US7368528 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration |
| 05/06/2008 | US7368452 for complex formation of hepatitis C non-structural protein-3 (NS3) with NS4A; enhancing the proteolytic efficacy at all of the sites; prevent reproduction of hepatitis virus |
| 05/06/2008 | US7368433 Acetyl-Z-Q-arg-trp-NH2 in which z is derived from amino-2-naphthalenecarboxylic acid and Q is derived from p-iodo-(D)phenylalanine; melanocortin-4 receptor agonist activity; treating obesity, hypertension, type II diabetes, or control of appetite |
| 05/06/2008 | US7368424 peptide antibiotics comprising lysobactin derivatives used for treatment and/or prophylaxis of bacterial infectious diseases; cyclic peptides |
| 05/06/2008 | US7368422 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 05/06/2008 | US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| 05/06/2008 | US7368236 Methods of producing nucleic acid ligands |
| 05/06/2008 | US7368119 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 05/06/2008 | CA2125636C Process for preparing an .alpha.-amino acid amide, useful for peptidic synthesis |
| 05/02/2008 | WO2008050161A2 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 05/02/2008 | WO2008050133A2 Inhibition of beta-amyloid aggregation |
| 05/02/2008 | WO2008049866A1 New chelating compound |
| 05/02/2008 | WO2008049832A1 Furanone derivatives as cysteine protease inhibitors |
| 05/02/2008 | WO2008049583A2 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | CA2667231A1 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | CA2667165A1 Hcv ns3 protease inhibitors |
| 04/30/2008 | EP1916248A1 Furanone derivatives as cysteine protease inhibitors |
| 04/30/2008 | EP1915621A2 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 04/30/2008 | EP1506168B1 Gelling agents |
| 04/30/2008 | EP1406651B1 Cosmetic or dermatological use of a peptide for promoting adhesion between skin cells |
| 04/30/2008 | EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 04/30/2008 | DE102006050672A1 New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations |
| 04/30/2008 | CN100384869C Diisopropoxy phosphoryl dipeptide trimethoxy benzamide compound and its preparation process |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |